Zoster in patients infected with HIV: A review

Citation
A. Vafai et M. Berger, Zoster in patients infected with HIV: A review, AM J MED SC, 321(6), 2001, pp. 372-380
Citations number
88
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
ISSN journal
00029629 → ACNP
Volume
321
Issue
6
Year of publication
2001
Pages
372 - 380
Database
ISI
SICI code
0002-9629(200106)321:6<372:ZIPIWH>2.0.ZU;2-#
Abstract
Varicella-zoster virus (VZV), a member of the human herpesvirus family, cau ses childhood chickenpox (varicella), becomes latent in sensory ganglia, an d reactivates years later in immunocompromised and elderly persons to produ ce shingles (herpes tester). Early in the AIDS epidemic, tester was noted i n adults and children infected with HIV. Severe and debilitating zoster-ass ociated dermatological, ophthalmic, and neurological complications may occu r in patients infected with HIV. Antiviral therapy can modify the duration of tester and alleviate its attendant complications. Varicella vaccine may boost the immunity and prevent virus reactivation. VZV immune globulin (VZI G) prevents or modifies clinical illness in persons who have been exposed t o varicella or tester.